Canaccord goes private as CEO ties deal to UK wealth sale
Canaccord Genuity Group Inc. has agreed to be taken private by Chairman and CEO Dan Daviau in an all-cash deal worth about C$15.27 per common share, contingent on selling its UK & Crown Dependencies wealth management business to affiliates of Centerbridge Partners and Mubadala. Closing is targeted for the first half of 2027.
Key Takeaways
- Common shareholders would receive about C$15.27 per share in cash, subject to GBP/CAD moves until closing.
- About C$7.45 covers the remaining business; roughly £4.15 per share is tied to UK wealth sale proceeds.
- The take-private needs the wealth sale to close, but the wealth sale can proceed on its own.
- Holders of about 35% of common shares, including convertibles, have indicated support.
- A Special Committee unanimously recommended the deal after an independent valuation and fairness opinions.
What happened in the Canaccord take-private deal?
Toronto-listed Canaccord Genuity (TSX: CF) said it signed an arrangement agreement with CG Acquisitionco Inc., an entity wholly owned by Dan Daviau. The buyer would acquire all common shares not held by Daviau and his affiliates for cash made up of C$7.45 plus £4.15 linked to anticipated proceeds from the UK wealth sale.
Based on the GBP/CAD rate as of November 13, 2026, that sterling portion equals about C$7.82, for total consideration of roughly C$15.27 per share. Series C preferred holders would receive C$25.30 per share in cash, plus accrued and unpaid dividends.
According to the company's announcement carried on Yahoo Finance, a Special Committee of independent directors unanimously recommended the transaction, and the board approved it with Daviau abstaining.
How does the UK wealth sale fit into the deal?
On the same day, Canaccord said affiliates of Centerbridge Partners, L.P. and Mubadala Investment Company PJSC will buy 100% of its UK & Crown Dependencies wealth management business, known as CGWM UK. That wealth disposal is central to the structure and cash available for the take-private.
Completion of the go-private deal is conditional on finishing the CGWM UK sale. The wealth sale is not contingent on privatization and is intended to proceed either way. Canaccord's UK capital markets business is excluded and remains part of the group's global capital markets operations.
If privatization fails after the wealth sale, the company said there is no assurance net proceeds would be distributed to shareholders. It could instead reduce leverage, pursue acquisitions, invest in the business, or return capital.
Why does this matter for wealth and shareholders?
The dual announcement is a major liquidity event and a reshaping of Canaccord's wealth footprint. Management argued that after selling the UK wealth arm, the remaining public company would be smaller, less diversified, and more exposed to cyclical capital markets earnings.
Daviau said private ownership should offer more flexibility to invest in people, strengthen capabilities, and pursue long-term growth. The company cited a 26.7% premium to the February 13, 2026 close of C$12.05—the last session before it disclosed it was assessing options for CGWM UK—and a 7.8% premium to the 30-day VWAP ended November 13, 2026.
An independent formal valuation put fair market value between C$14.60 and C$15.67 per common share, with the offered C$15.27 inside that range. A 45-day go-shop period runs through December 30, 2026. For more coverage in this beat, visit BlasterPost's Net Worth & Wealth hub.
Shareholder, court, and regulatory approvals are still required. A special meeting is expected in the first quarter of 2027, with closing eyed for the first half of 2027.